Sergio B. Socias
San Miguel De Tucuman, T, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
DDOX expands the repertoire of tetracyclines for Parkinson's disease by preventing the cellular uptake and intracellular impact of α-synuclein preformed fibrils.
Journal: Scientific reports
Published: January 23, 2025
Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson's Disease.
Journal: ACS chemical neuroscience
Published: July 11, 2024
Humoral Immune Response to SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases.
Journal: Archives of medical research
Published: April 17, 2024
Magnetic amyloid-based biocatalyst for the hydrolysis of urea.
Journal: Food chemistry
Published: March 08, 2023
Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.
Journal: Lancet regional health. Americas
Published: November 29, 2021
Elevated Humoral Immune Response to SARS-CoV-2 at High Altitudes Revealed by an Anti-RBD "In-House" ELISA.
Journal: Frontiers in medicine
Published: June 05, 2021
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity.
Journal: Frontiers in aging neuroscience
Published: November 30, 2020
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects.
Journal: Scientific reports
Published: June 23, 2020
Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: April 18, 2018
Exploiting the therapeutic potential of ready-to-use drugs: Repurposing antibiotics against amyloid aggregation in neurodegenerative diseases.
Journal: Progress in neurobiology
Published: July 20, 2017
Last Updated: 09/26/2026